ArticleIrish journal of medical science2026
Assessment of inflammatory and glycemic markers for in-hospital mortality in STEMI patients.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic Value of the Osaka Prognostic Score for One-Year Mortality in Patients with ST-Segment Elevation Myocardial Infarction: A Retrospective Observational Cohort Study.Journal of clinical medicine · 2026Article
- The leukocyte glucose index: a novel inflammatory-glucose biomarker for prevalent diabetic retinopathy and its supplementary predictive capacity in individuals with type 2 diabetes mellitus.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundST-elevation myocardial infarction (STEMI) is a critical form of acute coronary syndrome associated with high morbidity and mortality. Inflammation and stress-induced hyperglycemia play significant roles in its pathophysiology. This study aimed to evaluate the prognostic value of inflammatory and glycemic markers for in-hospital mortality in STEMI patients.
methodsA total of 119 patients diagnosed with STEMI were included in the study. Demographic characteristics, laboratory parameters, inflammatory and glycemic indices of the patients were recorded. The relationship between in-hospital mortality and the variables was assessed using univariate and multivariate logistic regression analyses. The prognostic performances of the indices were evaluated using Receiver Operating Characteristic (ROC) curve analysis.
resultsA total of 119 patients (mean age 63.1 ± 1.2 years; 77.3% male) were included. In-hospital mortality occurred in 11.8% of patients. Deceased patients had significantly higher leukocyte and neutrophil counts, neutrophil-to-lymphocyte ratio, glucose, leukoglycemic index (LGI), neutrophil glycemic index (NGI), neutrophil lymphocyte glycemic index (NLGI), urea, and creatinine levels, and lower hemoglobin levels. Multivariate logistic regression identified glucose, LGI, NGI, and NLGI as independent predictors of in-hospital mortality. NGI showed the highest area under the ROC curve (AUC: 0.790, 95% CI: 0.664–0.917).
conclusionGlycemic indices are independent predictors of in-hospital mortality in patients with STEMI. NGI reflects both the inflammatory response, represented by neutrophils, and glycemic stress, thus showing higher prognostic performance than other indices in the acute phase of STEMI. These findings suggest that NGI may serve as a practical and effective biomarker for risk stratification in STEMI.
Indexed as
Identifiers
41533267What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.